Kaori Muraji

Introduction: Kaori Muraji, a talented inventor based in Aichi, Japan, has made significant contributions to the field of pharmaceuticals. With a unique focus on novel crystal forms, she has developed innovative solutions that advance the understanding of drug formulations and their applications.

Latest Patents: Kaori Muraji holds a patent for novel crystal forms of a compound identified as 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]oxy}methyl)piperidin-1-yl]methyl}-tetrahydro-2H-pyran-4-carboxylic acid. This patent includes multiple polymorph forms: Polymorph Form I, Form II, Form III, Form IV, Form V, and Form VI. The invention also covers the processes for preparing these polymorph forms, as well as compositions containing them and potential uses.

Career Highlights: Kaori Muraji's career is marked by her dedication to research and development within the pharmaceutical industry. Working at Raqualia Pharma Inc., she has established herself as a prominent figure in her field, driving forward innovative ideas and solutions.

Collaborations: In her journey, Kaori collaborates closely with her colleague Toyoharu Numata, who shares her passion for innovation and development within the pharmaceutical sector. Their teamwork exemplifies the collective effort needed to push boundaries in science and technology.

Conclusion: Kaori Muraji is an inventor whose work in creating novel polymorph forms is paving the way for advancements in drug formulation. Her dedication, combined with collaborations with talented individuals like Toyoharu Numata, underscores the importance of teamwork in the pursuit of scientific excellence. With her ongoing contributions, Kaori continues to be a valuable asset to the field of pharmaceuticals.

Profile summary based on public USPTO records.